Dec 1, 2025 08:05AM
Dec 1, 2025 08:00AM
Nov 19, 2025 02:44PM
Nov 19, 2025 02:42PM
Nov 19, 2025 02:42PM
Nov 13, 2025 08:45AM
Nov 13, 2025 08:45AM Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
Oct 13, 2025 08:46AM
Oct 13, 2025 08:45AM
Sep 9, 2025 08:00AM
Sep 9, 2025 08:00AM
Jul 14, 2025 08:32AM
Jul 14, 2025 08:30AM
Jul 9, 2025 08:35AM Salarius reports studies support seclidemstat's LSD1 inhibition role
Jul 9, 2025 08:30AM
Apr 16, 2025 08:00AM
Feb 3, 2025 08:02AM
Feb 3, 2025 08:00AM
Jan 13, 2025 08:00AM
Mar 22, 2024 04:05PM
Feb 22, 2024 08:00AM Salarius Pharmaceuticals (SLRX) Issues Update on Strategic Review Process, Will Support Ongoing Seclidemstat Clinical Trials by Further Cost Cuts
Feb 22, 2024 08:00AM
Jan 16, 2024 08:17AM
Jan 16, 2024 08:00AM
Jan 3, 2024 08:54AM
Jan 3, 2024 08:30AM
Nov 7, 2023 08:31AM
Nov 7, 2023 08:30AM Salarius Completes FDA Type B Meeting for Seclidemstat Ewing Sarcoma Development Program
Aug 10, 2023 04:05PM
Aug 8, 2023 04:10PM
Aug 8, 2023 04:05PM
Jul 11, 2023 08:33AM
Jul 11, 2023 08:30AM
Jun 12, 2023 08:01AM
Jun 12, 2023 08:00AM Salarius Pharmaceuticals Presents SP-3164 Targeted Protein Degrader Preclinical Data at the European Hematology Association 2023 Hybrid Congress
May 16, 2023 04:05PM
May 12, 2023 08:02AM
May 12, 2023 08:00AM
May 11, 2023 08:00AM
May 9, 2023 08:00AM
May 9, 2023 08:00AM
May 1, 2023 08:32AM Salarius Pharmaceuticals (SLRX) Reports No Adverse Safety Signals from Two Toxicology Studies of SP-3164
May 1, 2023 08:30AM
Apr 20, 2023 08:30AM
Apr 4, 2023 04:02PM
Mar 27, 2023 08:30AM
Mar 15, 2023 11:00AM
Mar 7, 2023 08:00AM
Feb 16, 2023 08:32AM Salarius Pharmaceuticals, Inc. (SLRX) Receives $1.48M from the Cancer Prevention and Research Institute of Texas
Feb 16, 2023 08:30AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All